Liposomes24–26,28–30,34–38,40–43,50
|
Spherical vesicles, characterized by a phospholipid bilayer (made of dipalmitoyl phosphatidylcholine, hydrogenated soya lecithin, fatty alcohol polyglycol ether, cholesterol, dicetylphosphate) and an aqueous core |
Controlled drug release; decreased skin irritation; reduced side effects of free drug; formulation versatility; increased drug solubilization; drug protection from light and oxygen |
Poor stability due to lipid peroxidation and accumulation in the upper skin layers; limited permeation through skin |
Clindamycin; retinoic acid; benzoyl peroxide; tea tree oil |
Niosomes22,44–48,50,51
|
Vesicles containing non-ionic surfactant bilayer (such as cetyl alcohol, decyl glucoside, Brij, polysorbates, spans, poloxamers, alkyl polyglucoside surfactants) enclosing an aqueous cavity |
Greater vesicle stability; non-toxic nature and lower cost than liposomes; improved drug permeation through the stratum corneum and higher skin retention |
Inability to reach the deeper skin layers |
Retinoic acid; terazotene |
Etho30,50,52–55,69–72
|
Elastic nanosystems containing phospholipids, high amount of ethanol, and water |
Excellent flexibility; ability to passage through stratum corneum; high loading capacity for lipophilic drugs; relatively simple and inexpensive to manufacture |
Skin irritation due to high concentration of alcohol and poor skin penetration |
Azelaic acid |
Ultraderformable vesicles18,49,52,56–62,64–-68
|
Deformable vesicles due to the presence of edge activator (such as sodium cholate, sodium deoxycholate, Span 80, Tween 80 and dipotassium glycyrrhizinate) |
High deformability; ability to destabilize skin lipid organization; increased permeation into the deeper skin layers |
Mechanism of action is still not clear; conflicting information on their ability to reach the systemic circulation |
Adapalene; benzoyl peroxide; retinoic acid; photosensitizer |
LeciPlex31,73
|
Vesicular nanocarrier containing a combination of phospholipids and cationic surfactants (such as didodecyldimethyl ammonium bromide, cetyltrimethylammonium bromide) |
Enhanced skin deposition |
Few studies on human skin have been performed |
Azelaic acid |
Invasomes31,50,52,73
|
Flexible carriers made of phosphatidylcholine, terpenes (such as limonene, cineole, fenchone, citral) and ethanol |
Enhanced drug percutaneous permeation, thus guaranteeing faster activity |
Irritation and toxicity may occur as a function of the used penetration enhancers. Mechanism of skin permeation not completely clear; few available studies |
Dapsone; azelaic acid; curcumin |